• Luongo R, Walsh RM, Verrillo A, Studer L, Baggiolini A. (2024), Protocol for generating human cortical organoids enriched in outer radial glia by guided differentiation. STAR Protocols. Sep 20;5(3).

  • Walsh RM*, Luongo R*, Giacomelli E*, Ciceri G*, Rittenhouse C*, Verrillo A, Galimberti M, Dickinson Bocchi V, Wu Y, Xu N, Mosole S, Muller J, Vezzoli E, Jungverdorben J, Zhou T, Barker RA, Cattaneo E, Studer L, Baggiolini A. (2024), Generation of human cerebral organoids with a structured outer subventricular zone. Cell Reports. Apr 23;43(4):114031.

  • Binet R, Lambert JP, Tomkova M, Tischfield S, Baggiolini A, Picaud S, Sarkar S, Louphrasitthiphol P, Dias D, Carreira S, Humphrey TC, Fillipakopoulos P, White R, Goding CR. (2024). DNA damage remodels the MITF interactome to increase melanoma genomic instability. Genes Dev. Feb 5.

  • Ciceri G, Baggiolini A, Cho HS, Kshirsagar M, Benito-Kwiecinski S, Walsh RM, Aromolaran KA, Gonzalez-Hernandez AJ, Munguba H, Koo SY, Xu N, Sevilla KJ, Goldstein PA, Levitz J, Leslie CS, Koche RP, Studer L. (2024). An epigenetic barrier sets the timing of human neuronal maturation. Nature. Jan 31.

  • Van Lent J, Baggiolini A. (2024). Harmony in chaos: understanding cancer through the lenses of developmental biology. Mol Oncol. Jan 29.

  • Hergenreder E, Minotti AP, Zorina Y, Oberst P, Zhao Z, Munguba H, Calder EL, Baggiolini A, Walsh RM, Liston C, Levitz J, Garippa R, Chen S, Ciceri G, Studer L. (2024). Combined small-molecule treatment accelerates maturation of human pluripotent stem cell-derived neurons. Nat Biotechnol, 2.

  • Veneruso V, Petillo E, Pizzetti F, Orro A, Comolli D, De Paola M, Verrillo A, Baggiolini A, Votano S, Castiglione F, Sponchioni M, Forloni G, Rossi F, Veglianese P. (2023). Synergistic Pharmacological Therapy to Modulate Glial Cells in Spinal Cord Injury. Adv Mater. e2307747.

  • Lumaquin-Yin D, Montal E, Johns E, Baggiolini A, Huang TH, Ma Y, LaPlante C, Suresh S, Studer L, White RM. (2023). Lipid droplets are a metabolic vulnerability in melanoma. Nat Commun. 2;14.

  • Fan Y, Hackland J, Baggiolini A, Hung LY, Zhao H, Zumbo P, Oberst P, Minotti AP, Hergenreder E, Najjar S, Huang Z, Cruz NM, Zhong A, Sidharta M, Zhou T, de Stanchina E, Betel D, White RM, Gershon M, Margolis KG, Studer L. (2023). hPSC-derived sacral neural crest enables rescue in a severe model of Hirschsprung's disease. Cell Stem Cell. 2;30(3)

  • Weiss JM, Hunter MV, Cruz NM, Baggiolini A, Tagore M, Ma Y, Misale S, Marasco M, Simon- Vermot T, Campbell NR, Newell F, Wilmott JS, Johansson PA, Thompson JF, Long GV, Pearson JV, Mann GJ, Scolyer RA, Waddell N, Montal ED, Huang TH, Jonsson P, Donoghue MTA, Harris CC, Taylor BS, Xu T, Chalign  R, Shliaha PV, Hendrickson R, Jungbluth AA, Lezcano C, Koche R, Studer L, Ariyan CE, Solit DB, Wolchok JD, Merghoub T, Rosen N, Hayward NK, White RM. (2022). Anatomic position determines oncogenic specificity in melanoma. Nature. 1–8

  • Baggiolini A*, Callahan SJ*, Montal E, Weiss JM, Trieu T, Tagore MM, Tischfield SE, Walsh RM, Suresh S, Fan Y, Campbell NR, Perlee SC, Saurat N, Hunter MV, Simon-Vermot T, Huang TH, Ma Y, Hollmann T, Tickoo SK, Taylor BS, Khurana E, Koche RP, Studer L**, White RM**. (2021). Developmental chromatin programs determine oncogenic competence in melanoma. Science 373.

  • Diener J*, Baggiolini A*, Pernebrink M, Dalcher D, Lerra L, Cheng PF, Varum S, H usel J, Stierli S, Treier M, Studer L, Basler K, Levesque M, Dummer R, Santoro R, Cantu C, Sommer L. (2021). Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4. Nat Commun 12, 5056.

  • Varum S, Baggiolini A, Zurkirchen L, Atak ZK, Cant  C, Marzorati E, Bossart R, Wouters J, H usel J, Tuncer E, Zingg D, Veen D, John N, Balz M, Levesque MP, Basler K, Aerts S, Zamboni N, Dummer R, Sommer L. (2019). Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation. Cell Stem Cell 24, 637–653.e9.

  • Koehler C, Nittner D, Rambow F, Radaelli E, Stanchi F, Vandamme N, Baggiolini A, Sommer L, Berx G, van den Oord JJ, Gerhardt H, Blanpain C, Marine JC. (2017). Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes. Cell Stem Cell 21, 679–693.e6.

  • Baggiolini A, Varum S, Mateos JM, Bettosini D, John N, Bonalli M, Ziegler U, Dimou L, Clevers H, Furrer R, Sommer L. (2015). Premigratory and Migratory Neural Crest Cells Are Multipotent In Vivo. Cell Stem Cell 16, 314–322.

  • Locatelli G, Baggiolini A, Schreiner B, Palle P, Waisman A, Becher B, Buch T. Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage. (2015). Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage. Journal of Neuroinflammation 12, 62.

  • Jacob C, Loetscher P, Engler S, Baggiolini A, Varum Tavares S, Brügger V, John N, Büchmann-M ller S, Snider PL, Conway SJ, Yamaguchi T, Matthias P, Sommer L, Mantei N, Suter U. HDAC1 and HDAC2 control the specification of neural crest cells into peripheral glia. (2014). HDAC1 and HDAC2 Control the Specification of Neural Crest Cells into Peripheral Glia. J. Neurosci. 34, 6112–6122.

  • Schwarz D, Varum S, Zemke M, Schoeler A, Baggiolini A, Draganova K, Koseki H, Schübeler D, Sommer L. (2014). Ezh2 is required for neural crest-derived cartilage and bone formation. Development 141, 867–877.

  • Jacob C, Christen CN, Pereira JA, Somandin C, Baggiolini A, Loetscher P, Ozcelik M, Tricaud N, Meijer D, Yamaguchi T, Matthias P, Suter U. HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells. (2011). HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells. Nat Neurosci 14, 429–436.